Delivery Order SPE2DB22D1106-SPE2DB25FEQD4
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,158.47 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by July 29, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $31,334.26 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $23,371.64. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $38,034.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Monovisc 88 mg/4 ml syringes. The contract, which is not set-aside and was competitively awarded, requires completion by June 18, 2025, with performance to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.59 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.34 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order is scheduled for completion by September 16, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,453.60 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order, issued on a firm fixed-price basis with no set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $9,217.60 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on April 23, 2025, with completion targeted for April 24, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,757.37 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a firm fixed-price basis with no set-aside designation, indicating it was...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQD4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $4.17K. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and is scheduled for completion by May 28, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99M and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company has an extensive portfolio of federal contract awards predominantly with DLA covering pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. As a child contract under the SPE2DX IDC, this delivery order reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive bidding and its significant role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/27/25 |